Current status of haploidentical stem cell transplantationDEY, Bimalangshu R; SPITZER, Thomas R.British journal of haematology. 2006, Vol 135, Num 4, pp 423-437, issn 0007-1048, 15 p.Article

Stem cell transplantation with reduced-intensity conditioning regimens : a review of ten years experience with new transplant concepts and new therapeutic agents : Reduced-intensity conditioning allogeneic stem cell transplantation: hype, reality or time for a rethink?BARRETT, A. J; SAVANI, B. N.Leukemia. 2006, Vol 20, Num 10, pp 1661-1672, issn 0887-6924, 12 p.Article

In a 12-allele analysis HLA-DPB1 matching is associated with improved OS in leukaemic and myelodysplastic patients receiving myeloablative T-cell-depleted PBSCT from unrelated donorsBURT, C; PARKER, A; MCQUAKER, G et al.Bone marrow transplantation (Basingstoke). 2014, Vol 49, Num 5, pp 657-663, issn 0268-3369, 7 p.Article

The evolution of hematopoietic SCT in myelodysplastic syndromeKINDWALL-KELLER, T; ISOLA, L. M.Bone marrow transplantation (Basingstoke). 2009, Vol 43, Num 8, pp 597-609, issn 0268-3369, 13 p.Article

High-dose chemotherapy with autologous stem-cell rescue in the treatment of patients with recurrent non-cerebellar primitive neuroectodermal tumorsBRONISCER, Alberto; NICOLAIDES, Theodore P; DUNKEL, Ira J et al.Pediatric blood & cancer. 2004, Vol 42, Num 3, pp 261-267, issn 1545-5009, 7 p.Article

Outpatient myeloablative allo-SCT: a comprehensive approach yields decreased hospital utilization and low TRMSOLOMON, S. R; MATTHEWS, R. H; BARRERAS, A. M et al.Bone marrow transplantation (Basingstoke). 2010, Vol 45, Num 3, pp 468-475, issn 0268-3369, 8 p.Article

Reduced-intensity conditioning for acute myeloid leukemia : is this strategy correct : Reduced-intensity conditioning allogeneic stem cell transplantation: hype, reality or time for a rethink?LAZARUS, H. M; ROWE, J. M.Leukemia. 2006, Vol 20, Num 10, pp 1673-1682, issn 0887-6924, 10 p.Article

Influence of comorbidities on transplant outcomes in patients aged 50 years or more after myeloablative conditioning incorporating fludarabine, BU and ATGEL KOURASHY, S; WILLIAMSON, T; QUINLAN, D et al.Bone marrow transplantation (Basingstoke). 2011, Vol 46, Num 8, pp 1077-1083, issn 0268-3369, 7 p.Article

Outcomes after myeloablative unrelated donor stem cell transplantation using both in vitro and in vivo T-cell depletion with alemtuzumabVON DEM BORNE, Peter A; BEAUMONT, Floor; STARRENBURG, C. W. J Ingrid et al.Haematologica (Roma). 2006, Vol 91, Num 11, pp 1559-1562, issn 0390-6078, 4 p.Article

Pre-engraftment syndrome after myeloablative dual umbilical cord blood transplantation: risk factors and response to treatmentKANDA, J; KAYNAR, L; GASPARETTO, C et al.Bone marrow transplantation (Basingstoke). 2013, Vol 48, Num 7, pp 926-931, issn 0268-3369, 6 p.Article

Factors predicting single-unit predominance after double umbilical cord blood transplantationRAMIREZ, P; WAGNER, J. E; DEFOR, T. E et al.Bone marrow transplantation (Basingstoke). 2012, Vol 47, Num 6, pp 799-803, issn 0268-3369, 5 p.Article

Impact of intensity of conditioning therapy in patients aged 40―60 years with AML/myelodysplastic syndrome undergoing allogeneic transplantationKHABORI, M. A; EL-EMARY, M; XU, W et al.Bone marrow transplantation (Basingstoke). 2011, Vol 46, Num 4, pp 516-522, issn 0268-3369, 7 p.Article

Long-term outcomes in patients with high-risk myeloid malignancies following matched related donor hematopoietic cell transplantation with myeloablative conditioning of BU, etoposide and CYNAIK, S; WONG, R; JOHNSTON, L et al.Bone marrow transplantation (Basingstoke). 2011, Vol 46, Num 2, pp 192-199, issn 0268-3369, 8 p.Article

Unrelated donor peripheral blood stem cell transplants incorporating pre-transplant in-vivo Alemtuzumab are not associated with any increased risk of significant acute or chronic graft-versus-host diseaseSHAW, Bronwen E; APPERLEY, Jane F; LEE, Julia et al.British journal of haematology. 2011, Vol 153, Num 2, pp 244-252, issn 0007-1048, 9 p.Article

Acute kidney injury following HCT: incidence, risk factors and outcomeLOPES, J. A; JORGE, S.Bone marrow transplantation (Basingstoke). 2011, Vol 46, Num 11, pp 1399-1408, issn 0268-3369, 10 p.Article

Intra-BM injection to enhance engraftment after myeloablative umbilical cord blood transplantation with two partially HLA-matched unitsBRUNSTEIN, C. G; BARKER, J. N; WEISDORF, D. J et al.Bone marrow transplantation (Basingstoke). 2009, Vol 43, Num 12, pp 935-940, issn 0268-3369, 6 p.Article

Fludarabine, amsacrine, high-dose cytarabine and 12 Gy total body irradiation followed by allogeneic hematopoietic stem cell transplantation is effective in patients with relapsed or high-risk acute lymphoblastic leukemiaZOHREN, F; CZIBERE, A; BRUNS, I et al.Bone marrow transplantation (Basingstoke). 2009, Vol 44, Num 12, pp 785-792, issn 0268-3369, 8 p.Article

Outcomes of a second non-myeloablative allogeneic stem cell transplantation following graft rejectionBYRNE, B. J; HORWITZ, M; LONG, G. D et al.Bone marrow transplantation (Basingstoke). 2008, Vol 41, Num 1, pp 39-43, issn 0268-3369, 5 p.Article

Unmanipulated or CD34 selected haplotype mismatched transplantsYUBIN KANG; CHAO, Nelson J; AVERSA, Franco et al.Current opinion in hematology. 2008, Vol 15, Num 6, pp 561-567, issn 1065-6251, 7 p.Article

Allogeneic peripheral blood stem cell graft composition affects early T-cell chimaerism and later clinical outcomes after non-myeloablative conditioningPANSE, J. P; HEIMFELD, S; SANDMAIER, B. M et al.British journal of haematology. 2005, Vol 128, Num 5, pp 659-667, issn 0007-1048, 9 p.Article

Expanding the role of umbilical cord blood transplantationBRUNSTEIN, Claudio G; SETUBAL, Daniela C; WAGNER, John E et al.British journal of haematology. 2007, Vol 137, Num 1, pp 20-35, issn 0007-1048, 16 p.Article

Haematopoietic stem cell transplantation with non-myeloablative conditioning in the outpatient setting: results, complications and admission requirements in a single institutionPETERSEN, Søren L; MADSEN, Hans O; RYDER, Lars P et al.British journal of haematology. 2004, Vol 125, Num 2, pp 225-231, issn 0007-1048, 7 p.Article

Anti-tumour response despite loss of donor chimaerism in patients treated with non-myeloablative conditioning and allogeneic stem cell transplantationDEY, Bimalangshu R; MCAFEE, Steven; SACHS, David et al.British journal of haematology. 2005, Vol 128, Num 3, pp 351-359, issn 0007-1048, 9 p.Article

Cyclosporine levels and rate of graft rejection following non-myeloablative conditioning for allogeneic hematopoietic SCTGERULL, S; ARBER, C; BUCHER, C et al.Bone marrow transplantation (Basingstoke). 2011, Vol 46, Num 5, pp 740-746, issn 0268-3369, 7 p.Article

Haematopoietic cell transplantation with non-myeloablative conditioning in Denmark : disease-specific outcome, complications and hospitalization requirements of the first 100 transplantsKORNBLIT, B; MASMAS, T; PETERSEN, S. L et al.Bone marrow transplantation (Basingstoke). 2008, Vol 41, Num 10, pp 851-859, issn 0268-3369, 9 p.Article